Published in

Springer Verlag, Journal Africain du Cancer, 1(7), p. 16-21

DOI: 10.1007/s12558-014-0340-y

Links

Tools

Export citation

Search in Google Scholar

Developmental Signaling Genes in Ameloblastoma

Journal article published in 2014 by K. Onyegbula, Olugbenga S. Onile ORCID, V. N. Okoje, C. I. Anumudu ORCID
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Context: This study investigated the presence or absence of -catenin and Patched1 (PTCH1) genes involved in the developmental pathway in ameloblastoma, in order to clarify the genetic etiology of this tumor. Aim: The aim of this study was to investigate whether PTCH11 and -catenin genes are involved in the development of ameloblastoma. Subjects and Methods: Archived formalin-fixed paraffin-embedded specimens of 89 ameloblastoma cases from the years 2000–2010 were genotyped by polymerase chain reaction (PCR). Results: A total of 21 (23.6%) of the 89 ameloblastoma cases were positive for -catenin gene, where 14/21 (66.7%) cases were mandibular ameloblastoma. Plexiform 5/21 (23.8%) and cystic 5/21 (23.8) ameloblastoma were the most regular histological type positive for -catenin. However, -catenin positive were more in the feminine gender (11/19, 57.9%) than the masculine (8/19, 42.1%). Only one case was positive for PTCH1 gene and this was histologically a mandibular site and plexiform type ameloblastoma. Conclusions: This study suggested that -catenin and PTCH1 genes may play an important role for the pathogenesis of ameloblastoma.